BeyondSpring (BYSI) Free Cash Flow (2016 - 2026)
BeyondSpring (BYSI) posted Free Cash Flow of -$3.3 million for Q1 2026, up 39.52% sequentially from -$5.5 million in Q4 2025, and up 21.63% YoY from -$2.7 million in Q1 2025.
BeyondSpring (BYSI) Free Cash Flow (2016 - 2026) Analysis & Trends
BeyondSpring has reported Free Cash Flow for 9 years, with the latest figure at -$3.3 million in Q1 2026.
- Quarterly Free Cash Flow rose 21.63% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.9 million (down 21.37% YoY) and the FY2025 annual result came in at -$19.8 million, down 18.91% from the prior year.
- Free Cash Flow climbed to -$3.3 million in Q1 2026 per BYSI's latest filing, from -$5.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $955000.0 in Q4 2024 and troughed at -$7.0 million in Q2 2024.
- A 3-year average of -$4.4 million and a median of -$5.3 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow sank 676.34% in 2025, then rose 21.63% in 2026.
- Over 3 years, Free Cash Flow stood at $955000.0 in 2024, then tumbled by 676.34% to -$5.5 million in 2025, then soared by 39.52% to -$3.3 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$3.3 million, -$5.5 million, and -$4.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - | -3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.78 Mn |
| Jun 30, 2026 | -3.78 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -4.19 Mn |
| Sep 30, 2025 | -4.19 Mn |
| Jun 30, 2025 | -5.87 Mn |
| Jun 30, 2025 | -5.87 Mn |
| Mar 31, 2025 | -4.25 Mn |
| Mar 31, 2025 | -4.25 Mn |
| Dec 31, 2024 | 955,000.00 |
| Dec 31, 2024 | 955,000.00 |
| Sep 30, 2024 | -5.29 Mn |
| Sep 30, 2024 | -5.29 Mn |
| Jun 30, 2024 | -6.99 Mn |
| Jun 30, 2024 | -6.99 Mn |
| Mar 31, 2024 | -5.34 Mn |
| Mar 31, 2024 | -5.34 Mn |